Navidea opens Boston-area business office
February 8, 2012 by leonardzehr · Leave a Comment
Navidea Biopharmaceuticals (AMEX:NAVB) has opened a business and commercial development office in Andover, MA to house its commercialization team handling in part the activities surrounding the anticipated launch of Lymphoseek radioactive diagnostic tracing agent later this year.
Lymphoseek is a proprietary radioactive tracing agent being developed for use in connection with gamma detection devices in a surgical procedure referred to as Intraoperative Lymphatic Mapping (ILM)
Navidea’s corporate headquarters, with clinical, manufacturing, regulatory and administration functions, remains in Dublin, OH.
In a statement, CEO Dr. Mark Pykett said the Boston area will enhance the company’s access to industry partners, key business and technical leaders, and major academic medical centers. “This is an important commercial and business development expansion for us . as we prepare for the anticipated marketing approval in the U.S. for Lymphoseek, international activities for the product, and the growth of our radiopharmaceutical pipeline.”
Listen to BioTuesdays 
